Professor of Cancer Prevention and Director of the 
Principal Investigator leading the 
https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/09/HIP-1.png
638
736
cbrcprod
https://cambridgebrc.nihr.ac.uk/wp-content/uploads/2024/04/Cambridge_BRC_NIHR_logo.png
cbrcprod2024-09-10 15:04:502025-11-20 16:46:37Team’s hip replacement surgery invention is set to be world first
The NIHR Cambridge BRC is part of the NIHR and hosted by Cambridge University Hospitals NHS Foundation Trust in partnership with the University of Cambridge. We are at the heart of the Cambridge Biomedical Campus, Europe’s largest health research area.
Contact Us
Cambridge Biomedical Research Centre
Box 277
Hills Road
Cambridge
CB2 0QQ
Tel: 01223 348490
Are you looking for guidance on setting up a clinical trial? Look no further!
The #CTToolkit is an interactive colour-coded routemap that provides guidance on legal and best practice requirements. Bursting with advice, it's a must-see for any aspiring researcher ➡️
The Lung Immune Challenge Study, led by @Akhilesh_Jha (@HLRI_Cambridge), has reached a milestone with the final participant completing the first phase designed to investigate how immune systems respond to viral lung infections.
➡️ https://buff.ly/tXrD5v8
@The_MRC @CambridgeBRC
Learn about two upcoming career development awards that can support you in undertaking short placements in another part of NIHR or a local authority to enhance your research training experience and academic career development.
📅 Join our webinar from 12-1pm on 3 September to
Laura, the one of the first patients in the world to receive a new treatment for lupus from @CUH_NHS has welcomed news of a larger trial, offering the therapy to others. 'It has given me back so much freedom'
@Cambridge_Uni @NIHRresearch
To learn more:
Randomized Trial of Closed-Loop Control in Very Young Children with Type 1 Diabetes
Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial
Multicentre clinical evaluation of the safety and performance of a simple transperineal access system for prostate biopsies for suspected prostate cancer: The CAMbridge PROstate Biopsy DevicE (CamPROBE) study